Jonathan B. Strober MD
Neuromuscular Medicine
Clinical Professor, Neurology & Pediatrics
Join to View Full Profile
550 16th StreetSan Francisco, CA 94158
Phone+1 415-353-3651
Fax+1 415-353-2400
Dr. Strober is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Strober is a Child Neurologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from Temple University School of Medicine and has been in practice 25 years. He specializes in neuromuscular medicine and is experienced in child neurology, electromyography, neurodevelopmental disabilities, pediatric epilepsy, and pain management.
Education & Training
Emory University School of MedicineResidency, Neuromuscular Medicine (Neurology), 1998 - 1999
Children's Hospital of PhiladelphiaFellowship, Child Neurology, 1995 - 1998
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1992 - 1995
Lewis Katz School of Medicine at Temple UniversityClass of 1992
Certifications & Licensure
CA State Medical License 1999 - 2027
PA State Medical License 1995 - 2000
GA State Medical License 1998 - 1999
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects Start of enrollment: 2009 Nov 01
- Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD) Start of enrollment: 2011 Jun 01
- Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2016 Jan 04
Publications & Presentations
PubMed
- Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases.Jiachen Zhou, Sigrid Nilius, Olga Pilipczuk, Anna Scowcroft, Thaïs Tarancón
Neurology. 2025-07-08 - 1 citationsHeterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.Pascale Sabeh, Samantha A Dumas, Claudia Maios, Hiba Daghar, Marek Korzeniowski
American Journal of Human Genetics. 2025-01-02 - Analysis of Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society.Jaclyn M Martindale, Alison L Christy, Grace Y Gombolay, Bhooma R Aravamuthan, Laura Jansen
Neurology. 2024-09-10
Press Mentions
Implications of Nipocalimab Approval on Pediatric Patients with Myasthenia GravisJune 25th, 2025
Sustained Disease Control in Adolescent Myasthenia Gravis with FcRn BlockerOctober 19th, 2024- Nipocalimab Demonstrates Sustained Disease Control in Adolescents Living with Generalized Myasthenia Gravis in Phase 2/3 StudyOctober 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
